Skip to main content
AAPL+0.64%MSFT+1.07%NVDA+0.64%GOOGL+0.80%AMZN+1.46%SPCX+1.27%TSM+0.81%AVGO+3.64%META+0.81%TSLA+0.74%LLY-2.33%WMT-0.13%AMD+5.31%SKHY-0.11%JPM-1.77%BRK-B-2.07%MU+1.55%V-0.37%JNJ-2.15%XOM-3.97%MA-0.37%ASMLa+1.94%ABBV-2.33%COST-1.21%1398.HK-0.79%KO-0.71%0700.HK-6.52%CVX-4.74%PG-0.83%CSCO+2.18%0939.HK-0.14%ORCL-0.97%3988.HK-0.60%GE+0.52%BAC-1.07%HD-0.40%1816.HK-26.80%0857.HK-2.43%UNH-10.21%1288.HK-1.49%PM-0.85%0005.HK-2.10%NVS-2.46%INTC-0.91%HSBA.L-2.00%MS-1.29%AMAT+0.88%AP2d+2.23%AZN-1.93%TXN-1.16%AUDJPY-1.54%AUDUSD-1.45%AUDNZD-0.90%AUDCAD-0.88%EURAUD+0.88%AUDCHF-0.86%GBPAUD+0.82%GBPJPY-0.73%EURJPY-0.69%CHFJPY-0.68%CADJPY-0.67%NZDJPY-0.66%USDCHF+0.62%GBPUSD-0.62%USDCAD+0.59%EURUSD-0.58%NZDUSD-0.55%AUDSGD-0.51%USDZAR+0.44%AUDDKK-0.44%GBPTRY+0.41%NZDMXN+0.41%USDMXN+0.36%USDTHB+0.33%GBPHKD+0.32%AUDNOK-0.31%EURZAR+0.29%GBPMXN-0.28%GBPZAR+0.28%USDNOK+0.27%USDTRY+0.21%USDSEK+0.20%CHFNOK+0.20%USDPLN+0.20%EURCNH-0.18%NOKJPY-0.16%USDILS+0.16%EURHKD-0.15%USDDKK+0.14%NZDSGD+0.13%CHFSEK+0.13%EURNOK+0.13%USDCNH-0.12%USDJPY-0.11%GBPSGD-0.09%EURSGD-0.08%PLNJPY-0.08%GBPNZD-0.08%USDSGD+0.06%EURSEK+0.06%SGDJPY+0.06%GBPCAD-0.06%EURPLN+0.05%EURGBP+0.04%NZDCHF+0.04%USDCOP-0.04%EURCHF+0.04%EURCZK+0.04%EURNZD-0.03%CADCHF+0.03%USDHKD-0.02%CHFSGD-0.01%NZDCAD+0.01%EURCAD0.00%GBPCHF0.00%EURDKK0.00%XNGUSD-0.83%XPTUSD-0.74%W1-0.53%C1-0.41%XAUUSD-0.34%GAUUSD-0.34%GAGUSD-0.30%XAGUSD-0.30%HG1-0.25%UKOIL+0.21%S1-0.17%USOIL-0.08%BTCUSD-3.00%ETHUSD+57.77%USDTUSD0.00%XRPUSD+52.58%SOLUSD+57.55%TRXUSDT+0.77%ZECUSDT-6.20%XMRUSDT-1.74%DOGEUSD+55.95%LINKUSD-2.81%XLMUSD-3.27%BCHUSDT-3.12%LTCUSD+47.50%UNIUSD-2.50%SUIUSD-2.33%TONUSD+59.18%HBARUSDT-4.83%TAOUSDT-2.55%AAVEUSD-2.89%ONDOUSDT-4.61%ICPUSDT-1.52%DOTUSDT-3.36%WLDUSDT-3.20%ARBUSDT-5.21%ATOMUSDT-2.01%INJUSDT-6.85%STXUSDT-2.39%PYTHUSDT+0.21%TIAUSDT-2.54%FETUSDT-4.01%JUPUSDT+0.82%SEIUSDT-4.48%GRTUSDT-2.94%OPUSDT-2.63%IOTAUSDT-2.25%POLUSDT-1.58%WIFUSDT-2.25%AXSUSDT-2.47%EOSUSDT-3.88%IMXUSDT-3.36%FARTCOINUSDT-6.30%GALAUSDT-1.65%DYDXUSDT-2.37%ORDIUSDT-2.00%NOTUSDT-0.74%RONINUSDT-2.92%AAPL+0.64%MSFT+1.07%NVDA+0.64%GOOGL+0.80%AMZN+1.46%SPCX+1.27%TSM+0.81%AVGO+3.64%META+0.81%TSLA+0.74%LLY-2.33%WMT-0.13%AMD+5.31%SKHY-0.11%JPM-1.77%BRK-B-2.07%MU+1.55%V-0.37%JNJ-2.15%XOM-3.97%MA-0.37%ASMLa+1.94%ABBV-2.33%COST-1.21%1398.HK-0.79%KO-0.71%0700.HK-6.52%CVX-4.74%PG-0.83%CSCO+2.18%0939.HK-0.14%ORCL-0.97%3988.HK-0.60%GE+0.52%BAC-1.07%HD-0.40%1816.HK-26.80%0857.HK-2.43%UNH-10.21%1288.HK-1.49%PM-0.85%0005.HK-2.10%NVS-2.46%INTC-0.91%HSBA.L-2.00%MS-1.29%AMAT+0.88%AP2d+2.23%AZN-1.93%TXN-1.16%AUDJPY-1.54%AUDUSD-1.45%AUDNZD-0.90%AUDCAD-0.88%EURAUD+0.88%AUDCHF-0.86%GBPAUD+0.82%GBPJPY-0.73%EURJPY-0.69%CHFJPY-0.68%CADJPY-0.67%NZDJPY-0.66%USDCHF+0.62%GBPUSD-0.62%USDCAD+0.59%EURUSD-0.58%NZDUSD-0.55%AUDSGD-0.51%USDZAR+0.44%AUDDKK-0.44%GBPTRY+0.41%NZDMXN+0.41%USDMXN+0.36%USDTHB+0.33%GBPHKD+0.32%AUDNOK-0.31%EURZAR+0.29%GBPMXN-0.28%GBPZAR+0.28%USDNOK+0.27%USDTRY+0.21%USDSEK+0.20%CHFNOK+0.20%USDPLN+0.20%EURCNH-0.18%NOKJPY-0.16%USDILS+0.16%EURHKD-0.15%USDDKK+0.14%NZDSGD+0.13%CHFSEK+0.13%EURNOK+0.13%USDCNH-0.12%USDJPY-0.11%GBPSGD-0.09%EURSGD-0.08%PLNJPY-0.08%GBPNZD-0.08%USDSGD+0.06%EURSEK+0.06%SGDJPY+0.06%GBPCAD-0.06%EURPLN+0.05%EURGBP+0.04%NZDCHF+0.04%USDCOP-0.04%EURCHF+0.04%EURCZK+0.04%EURNZD-0.03%CADCHF+0.03%USDHKD-0.02%CHFSGD-0.01%NZDCAD+0.01%EURCAD0.00%GBPCHF0.00%EURDKK0.00%XNGUSD-0.83%XPTUSD-0.74%W1-0.53%C1-0.41%XAUUSD-0.34%GAUUSD-0.34%GAGUSD-0.30%XAGUSD-0.30%HG1-0.25%UKOIL+0.21%S1-0.17%USOIL-0.08%BTCUSD-3.00%ETHUSD+57.77%USDTUSD0.00%XRPUSD+52.58%SOLUSD+57.55%TRXUSDT+0.77%ZECUSDT-6.20%XMRUSDT-1.74%DOGEUSD+55.95%LINKUSD-2.81%XLMUSD-3.27%BCHUSDT-3.12%LTCUSD+47.50%UNIUSD-2.50%SUIUSD-2.33%TONUSD+59.18%HBARUSDT-4.83%TAOUSDT-2.55%AAVEUSD-2.89%ONDOUSDT-4.61%ICPUSDT-1.52%DOTUSDT-3.36%WLDUSDT-3.20%ARBUSDT-5.21%ATOMUSDT-2.01%INJUSDT-6.85%STXUSDT-2.39%PYTHUSDT+0.21%TIAUSDT-2.54%FETUSDT-4.01%JUPUSDT+0.82%SEIUSDT-4.48%GRTUSDT-2.94%OPUSDT-2.63%IOTAUSDT-2.25%POLUSDT-1.58%WIFUSDT-2.25%AXSUSDT-2.47%EOSUSDT-3.88%IMXUSDT-3.36%FARTCOINUSDT-6.30%GALAUSDT-1.65%DYDXUSDT-2.37%ORDIUSDT-2.00%NOTUSDT-0.74%RONINUSDT-2.92%
RT

Relay Therapeutics, Inc. (RLAY)

NASDAQ • Healthcare

$16.51
+$0.04 (+0.2%)
Market closed

Last close at November 18, 2026 at 21:00 UTC

Open$16.41
Day Range$16.27 - $17.14
Avg. Volume (3M)2.5M
Market Cap$3.6B
52 Week Range
$6.28$21.27

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$10.3M
Net Income (TTM)
-$293.6M
EPS (TTM)
-$1.51
ROA (TTM)
-32.56%
Current Ratio
14.62

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-17.1%Q2 2026-$0.41
-4.8%Q3 2026-$0.41
+6.7%Q4 2026-$0.37

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +6.7%

Relay Therapeutics topped consensus EPS expectations in the third fiscal quarter of 2026, reported November 4, 2026, with EPS of -$0.37 topping the -$0.40 estimate by $0.03, based on preliminary results. The biotech posted a GAAP operating loss of roughly $90.2 million and a GAAP net loss of about $81.7 million, a net income result that was down 10.2% year over year from about -$74.1 million a year ago. Operating cash flow was negative at roughly $63.9 million as the company continued funding its oncology-focused small-molecule pipeline work, including programs such as RLY-4008, RLY-1971, and RLY-2608. For the next period, consensus calls for EPS of -$0.37 on revenue of $7.3 million.

View full earnings history

About Relay Therapeutics, Inc.

Relay Therapeutics, Inc. is a NASDAQ-listed biotechnology company that develops small molecule therapies for cancer and genetic conditions through a precision-medicine approach and clinical trials. In FY2025, Relay Therapeutics generated $15.4 million in revenue. The company, formerly known as Allostery, Inc., is based in Cambridge, Massachusetts, was founded in 2015, and went public in 2020.

Name
Relay Therapeutics, Inc.
CEO
Sanjiv K. Patel
Industry
Healthcare
Year Founded
2015
Employees
202

Today's Snapshot

AI-generated

The day ended with RLAY slightly higher at 16.51, while its sector was weaker. Relay Therapeutics advanced zovegalisib, an experimental cancer drug, toward pivotal trials.

Trading Volume

Below 10d avg (2.7M)

2.4M

vs S&P 500 Today

Outperforming Market

+0.50%

Updated: November 18, 2026 at 21:23 UTC

Technical Indicators

2 Buy1 Neutral5 Sell
RLAY shows short-term weakness while longer-term breadth remains mixed; the ADX is low, indicating little trend conviction, and momentum indicators (negative momentum and a modestly bearish MACD) align with a subdued RSI near the lower neutral band. The stock trades below its short- and medium-term moving averages yet remains above the 200-day averages, suggesting recent pressure inside a longer-term base. Volatility is elevated relative to price, and on-balance volume is not supportive, leaving price action fragile around the pivot near 16.76. Technical takeaway: Sell — short-to-intermediate indicators favor sellers despite longer-term support.
All signals
  • EMA (5 indicators)$15.10 - $18.23
    Sell
  • RSI (14)40.57
    Neutral
  • Stochastic %K (14, 3, 3)8.25
    Buy
  • MACD Level (12, 26)-0.24
    Sell
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.